L

Ligand Pharmaceuticals
D

LGND

119.350
USD
2.54
(2.17%)
مغلق
حجم التداول
4,442
الربح لكل سهم
5
العائد الربحي
-
P/E
48
حجم السوق
2,255,162,768
نظرة عامةالتوصياتالأفكار والتحليلاتالأخبار
أصول ذات صلة
    A
    ACAD
    -0.240
    (-1.41%)
    16.790 USD
    A
    AGIO
    -1.645
    (-2.97%)
    53.810 USD
    ALNY
    ALNY
    -22.650
    (-8.77%)
    235.480 USD
    B
    BLUE
    -0.04270
    (-11.74%)
    0.32090 USD
    I
    ICPT
    0
    (0%)
    0.000000 USD
    I
    INCY
    -1.840
    (-2.37%)
    75.890 USD
    J
    JAZZ
    -2.620
    (-2.11%)
    121.660 USD
    N
    NBIX
    -5.465
    (-4.45%)
    117.410 USD
    VRTX
    VRTX
    -18.53
    (-3.83%)
    450.72 USD
    المزيد
الأخبار

العنوان: Ligand Pharmaceuticals

القطاع: Healthcare
الصناعة: Biotechnology
Ligand Pharmaceuticals Inc is a biopharmaceutical company focused on developing and acquiring technologies that aid in creating medicine. The company has partnerships and license agreements with various pharmaceutical and biotechnology companies. Ligand's business model is based on drug discovery, early-stage drug development, product reformulation, and partnerships. The company's revenue consists of three primary elements: royalties from commercialized products, license andmilestone payments, and sale of its trademarked Captisol material.